Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Hydrocortisone Versus Ondansetron in Prevention of Post Spinal Anesthesia Hypotension in Elective Surgeries

NCT06930456 is registered in ClinicalTrials.gov with Nada kamel Elgamal as lead sponsor.

NCT NCT06930456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06930456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Hydrocortisone Versus Ondansetron in Prevention of Post Spinal Anesthesia Hypotension in Elective Surgeries
Lead sponsor
Nada kamel Elgamal
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
March 1, 2024
Completion date
May 1, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post spinal anaesthesia hypotension